Should You Invest In These 5%+ Yielders? Anglo American plc, GlaxoSmithKline plc, Telecom Plus PLC & Admiral Group plc

Royston Wild explains the investment appeal of Anglo American plc (LON: AAL), GlaxoSmithKline plc (LON: GSK), Telecom plus PLC (LON: TEP) and Admiral Group plc (LON: ADM).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at whether you should stash your cash in these four big-yield behemoths.

Anglo American

At first glance Anglo American (LSE: AAL) may be an attractive pick for those seeking brilliant investment returns. According to City forecasts the mining colossus is set to deliver a dividend of 85 US cents per share in both 2015 and 2016, matching the payouts seen in the past three periods. Consequently the business offers a market-beating yield of 5.4% through to the close of next year.

But I believe that these predictions may fall short of estimates, as severe supply/demand imbalances across its critical markets threaten a fourth successive earnings slide for this year and potentially beyond. With Anglo American also nursing a $12.9bn net debt pile as of the turn of 2015 — and prospective dividends covered just 1.2 times and 1.6 times for this year and next, well below the safety market of 2 times — I believe the metals play is a perilous pick for income seekers.

GlaxoSmithKline

Conversely, I believe that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a strong dividend pick for the near term and stretching further ahead. The pharma giant announced plans last month to fork out an ordinary dividend of 80p per share through to the close of 2017, forecasts that carry a chunky yield of 5.4%.

Like Anglo American, GlaxoSmithKline boasts poor dividend cover for the next few years, with projected earnings of 81.9p for 2015 and 89.5p for next year barely exceeding expected dividends. But the Brentford firm remains a brilliant cash generator despite the effect of expiring patents on profits, and is also undertaking massive restructuring to bolster the balance sheet and cut the debt column still further. And with GlaxoSmithKline’s revitalised R&D department ready to drive revenues higher again from this year, I expect dividends to continue outperforming the wider market.

Telecom Plus

Shares in Telecom Plus (LSE: TEP) have gradually stepped lower in recent months as gas and electricity prices have headed steadily lower. However, the business is expected keep the likes of Centrica, SSE et al on the back foot by continually improving its tariff range —  as illustrated by March’s new two-year tariff, part-funded by nPower — while Telecom Plus’ strategy of rewarding existing customers rather than courting new clients is also helping to maintain its consumer base.

As a consequence Telecom Plus is expected to see earnings tick comfortably higher through the next few years at least, driving a predicted dividend of 40p per share for the year concluding March 2015 to 46p in 2016 and to 52p the following year. Consequently the business boasts vast yields of 5.7% for this year and 6.4% for 2017.

Admiral Group

Although car insurance specialist Admiral (LSE: ADM) remains beset by intense competition, I believe that a gradual improvement in premiums should keep dividends bubbling along at above-average levels. This view is shared by the City, and the Swansea-based firm is expected to fork out rewards of 89.1p this year and 94.8p in 2016. As a result the insurer carries gigantic yields of 6% and 6.4% for these years.

While dividend coverage may be lacking over at Admiral — estimated payments are barely covered by earnings through to the end of next year — the firm is a terrific capital generator and saw cash and cash equivalents leap to £255.9m last year from £187.9m in 2013. With its operations on mainland Europe also pulling up trees, and Admiral boasting terrific customer retention rates, I believe the Cardiff firm should remain a lucrative payout pick.

 

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Centrica. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How to turn a Stocks and Shares ISA into £10k of annual passive income

Mark Hartley outlines a simple method of achieving a stable passive income stream from a Stocks and Shares ISA without…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 useful lessons from Warren Buffett for an investor over 40

Can Warren Buffett's long-term approach to investing still work for someone in middle age, or older? Christopher Ruane believes it…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

This UK growth share’s already doubled this year. I reckon it might just be getting going!

This UK growth share has more than doubled in a matter of weeks. Our writer thinks the market may be…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How much do I need in an ISA for a £668 monthly second income?

One popular approach to building a second income is through becoming a landlord. But how does that compare to using…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

In just 2 years, Vodafone shares would have turned £10,000 into this much…

The Vodafone transformation is going well, and the shares have had a brilliant couple of years. Can the momentum and…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Down 9%! Here are 3 dangers that are emerging for Rolls-Royce shares

What has sent Rolls-Royce shares down sharply in the FTSE 100 over the past couple of days? Ben McPoland takes…

Read more »

Businessman with tablet, waiting at the train station platform
Growth Shares

Here’s what fresh legal news could mean for Lloyds shares

Jon Smith digests the latest news about the UK car loan scandal and outlines what it means for Lloyds shares,…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

A new risk has emerged for Rolls-Royce and it could send the share price back to 1,010p

All of a sudden, the Rolls-Royce share price is falling. Edward Sheldon believes that it could go lower before it…

Read more »